All Resources

Access to Medicine • November 17, 2022

Innovative Agreements Framework

Learn more | View

Economic Impact • October 07, 2022

Pre-Budget Consultations in Advance of the 2023 Budget

Learn more | View

Access to Medicine • July 06, 2022

Developing a Pan-Canadian Genomics Strategy: Innovative Medicines Canada Response

Learn more | View

Access to Medicine • February 12, 2022

Optimizing Patient Access to Precision Therapies: Preparing for the Emerging Era of Advanced Testing

Learn more | View

Access to Medicine • February 05, 2022

Bluesky Project

Reimagining Canada’s Approval and Reimbursement System for Innovative Medicines February 2022…

Learn more | View

January 14, 2022

2022 Ontario Pre-Budget Consultation

Learn more | View

Ethics • January 01, 2022

2022 Code of Ethical Practices

Learn more | View

Access to Medicine • November 15, 2021

Research Note: Oncology Clinical Trials: Canada Within the International Context

Clinical trials provide Canadian oncology patients with earlier access to new, innovative cancer treatments. But changes pending to the PMPRB will make the Canadian pharmaceutical market less attractive for investment….

Learn more | View

Drugs for Rare Diseases (DRD) • September 15, 2021

Addendum to IMC Submission on Drugs for Rare Diseases

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • June 21, 2021

Proposed Guidelines Monitoring and Evaluation Plan

Learn more | View

Economic Impact • May 30, 2021

The Canadian Research and Development Pharmaceutical Sector

Learn more | View

Access to Medicine • May 18, 2021

Clinical Trials in Canada – Numbers

Learn more | View